FDA: Recommended Pembrolizumab Dose Is 200 Mg Every 3 Weeks or 400 Mg Every 6 Weeks Until Disease Progression Unacceptable Toxicity or up to 24 Months
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.